Comerica Bank’s Caribou Biosciences CRBU Stock Holding History

Comerica Bank’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-127	Closed	-$249	–	3694
2024 Q3	$249	Hold	127	–	–	﹤0.01%	3637
2024 Q2	$208	Buy	+127	New	+$406	﹤0.01%	3661

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Comerica Bank's CRBU Position: Q4 2024 in Review

Comerica Bank sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 127 shares — an estimated $249 sold.

Comerica Bank first reported a position in CRBU in Q2 2024 and held it in 2 quarters. The position peaked at $249 in Q3 2024. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

Comerica Bank reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
Comerica Bank sold 127 Caribou Biosciences shares in Q4 2024, an estimated $249.
Comerica Bank first reported a position in Caribou Biosciences in Q2 2024 and held it in 2 quarters.
Comerica Bank's Caribou Biosciences position peaked at $249 in Q3 2024.
133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Comerica Bank's 13F filing for Q4 2024, filed 14 Feb 2025.